Skip to main content

BioPharma Credit

data as at: 12/09/2019
Company website
ObjectiveTo generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.
Management groupPharmakon Advisors
AIC sectorDebt - Direct Lending
Launch date27/03/2017
Financial year end31/12/2019
DomicileUK
Total assets (m)Price (last close)Price (bid)Price (offer)NAVDividend declared datesDiscount/
premium (%)
Gearing (%)5yr dividend growth (%) p.a.Dividend yield (%)
1,391.91.031.021.031.01Jan, Apr, Jul, Oct1.20N/A6.8

Dividends

Dividends displayed in traded currency.

Ex-Dividend DateDividend amountDividend typeSpecial dividend
15/08/20190.018IncomeNo
23/05/20190.018IncomeNo
28/02/20190.018IncomeNo
28/02/20190.002IncomeYes
01/11/20180.018IncomeNo
View dividend history
Dividend cover (years)Revenue reserves (m)
0.2422.80

Trading information

ISINTIDMTraded currency
GB00BDGKMY29BPCRUSD

Traded volumes (number of shares)

Yesterday1 month1 year5 years
Total2,420,00013,250,000188,470,0000
AverageN/A580,000750,0000

Traded values (m)

Yesterday1 month1 year5 years
Total0.0211.08155.55N/A
AverageN/A0.480.62N/A

Data provided by Morningstar. Company documents provided by Financial Express. 

Company announcements

Company documents